Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases
Genfit SA (NASDAQ:GNFT) has agreed to acquire the Swiss startup Versantis for CHF40 million upfront in a small-time buyout. The deal,…
Apple Sidesteps Feds On Weed As Health App Doesn’t Discriminate On Legality
With cannabis use becoming widespread, new challenges such as understanding and avoiding possible negative interactions with pharmaceutical drugs are important issues.
McKesson Buys Rx Savings Solutions For $875M
McKesson Corp (NYSE:MCK) has agreed to acquire Rx Savings Solutions (RxSS), a prescription price transparency and benefit insight company offering affordability and…
Beam Therapeutics Touts Encouraging Preclinical Data From Gene Editing Approach For Hepatitis B Infection
Beam Therapeutics Inc (NASDAQ:BEAM) announced new preclinical data demonstrating the potential of its multiplex base editing approach to reduce hepatitis B…
After US Study, Pfizer’s 20-Valent Pneumococcal Jab Aces European Infant Study
Pfizer Inc (NYSE:PFE) announced positive topline results from its European Phase 3 study in infants evaluating its 20-valent pneumococcal conjugate vaccine…
Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders
The European Commission approved Roche Holding AG’s (OTC:RHHBY) Vabysmo (faricimab) for neovascular or ‘wet’ age-related macular degeneration (nAMD) and visual impairment…
European Authority Backs AbbVie’s Crohn’s Disease Candidate
The European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending approval of AbbVie Inc’s (NYSE:ABBV)…
Virios Therapeutics Shares Tank After Failing Fibromyalgia Study
Virios Therapeutics Inc’s (NASDAQ:VIRI) shares crashed after its FORTRESS Phase 2b trial of IMC-1 antiviral combination therapy for fibromyalgia failed…
Teva To Start Nationwide Settlement Of Opioid Lawsuits From Next Year: Report
Reuters reported that Teva Pharmaceutical Industries Ltd’s (NYSE:TEVA) CEO said the company will finalize the U.S. opioid settlement by the end…
Valneva Cuts Ties With Its COVID-19 Vaccine Manufacturing Partner In Germany
Valneva SE (NASDAQ:VALN) and IDT Biologika will terminate their collaboration following the delivery of inactivated COVID-19 bulk vaccine to Valneva and…